Sirolimus-Based Therapy Following Early Cyclosporine Withdrawal Provides Significantly Improved Renal Histology and Function at 3 Years
Open Access
- 2 April 2004
- journal article
- clinical trial
- Published by Elsevier in American Journal of Transplantation
- Vol. 4 (6) , 953-961
- https://doi.org/10.1111/j.1600-6143.2004.00446.x
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Chronic Renal Failure after Transplantation of a Nonrenal OrganNew England Journal of Medicine, 2003
- Everolimus for the Prevention of Allograft Rejection and Vasculopathy in Cardiac-Transplant RecipientsNew England Journal of Medicine, 2003
- Predicting long-term kidney graft survival: can new trials be performed?1,2Transplantation, 2003
- Protocol Core Needle Biopsy and Histologic Chronic Allograft Damage Index (CADI) as Surrogate End Point for Long-Term Graft Survival in Multicenter StudiesJournal of the American Society of Nephrology, 2003
- Post-transplant renal function in the first year predicts long-term kidney transplant survivalKidney International, 2002
- Sirolimus Does Not Exhibit Nephrotoxicity Compared to Cyclosporine in Renal Transplant RecipientsAmerican Journal of Transplantation, 2002
- Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: a randomised multicentre studyThe Lancet, 2000
- Nephrotoxicity of immunosuppressive drugs: Long-term consequences and challenges for the futureAmerican Journal of Kidney Diseases, 2000
- The Banff 97 working classification of renal allograft pathologyKidney International, 1999
- THE EFFECT OF RAPAMYCIN ON KIDNEY FUNCTION IN THE SPRAGUE-DAWLEY RATTransplantation, 1992